Literature DB >> 12740391

Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.

Rebecca B Riggins1, Lawrence A Quilliam, Amy H Bouton.   

Abstract

The adapter molecule p130Cas (Cas) plays a role in cellular processes such as proliferation, survival, cell adhesion, and migration. The ability of Cas to promote migration has been shown to be dependent upon its carboxyl terminus, which contains a bipartite binding site for the protein tyrosine kinase c-Src (Src). The association between Src and Cas enhances Src kinase activity, and like Cas, Src plays an important role in cell proliferation and migration. In this study, we show that Src and Cas function cooperatively to promote cell migration in a manner that depends upon kinase-active Src. Another carboxyl-terminal binding partner of Cas, AND-34/BCAR3 (AND-34), functions synergistically with Cas to enhance Src activation and cell migration. The carboxyl-terminal guanine nucleotide exchange factor domain of AND-34, as well as the activity of its putative target Rap1, contribute to these events. A mechanism through which AND-34 may regulate Cas-dependent cell migration is suggested by the finding that Cas becomes redistributed from focal adhesions to lamellipodia located at the leading edge of AND-34 overexpressing cells. These data thus provide insight into how Cas and AND-34 may function together to stimulate Src signaling pathways and promote cell migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740391     DOI: 10.1074/jbc.M303535200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.

Authors:  Virginie S Vervoort; Séverine Roselli; Robert G Oshima; Elena B Pasquale
Journal:  Gene       Date:  2007-01-08       Impact factor: 3.688

2.  Differential dependency network analysis to identify condition-specific topological changes in biological networks.

Authors:  Bai Zhang; Huai Li; Rebecca B Riggins; Ming Zhan; Jianhua Xuan; Zhen Zhang; Eric P Hoffman; Robert Clarke; Yue Wang
Journal:  Bioinformatics       Date:  2008-12-26       Impact factor: 6.937

Review 3.  Biological determinants of endocrine resistance in breast cancer.

Authors:  Elizabeth A Musgrove; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

4.  BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.

Authors:  Pierre Vanden Borre; Richard I Near; Anthony Makkinje; Gustavo Mostoslavsky; Adam Lerner
Journal:  Cell Signal       Date:  2011-01-22       Impact factor: 4.315

5.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

Review 6.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

7.  Roles for crk in cancer metastasis and invasion.

Authors:  Masumi Tsuda; Shinya Tanaka
Journal:  Genes Cancer       Date:  2012-05

8.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

Review 9.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

10.  BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling.

Authors:  Natasha R Schuh; Michael S Guerrero; Randy S Schrecengost; Amy H Bouton
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.